GlassScriptPhysician profile
Barnabas Hines
NPI 1114267119
$10,527.97
in general payments reported to CMS, 2019-2025
53 companies · $2,077 in 2025
The $2,077 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $1,404 · 2021: $1,517 · 2022: $850 · 2023: $1,572 · 2024: $1,928 · 2025: $2,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,577.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,380.63 | 2020-2025 | |
| Glaxosmithkline, LLC. | $1,063.65 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $870.03 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $779.38 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $757.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $605.51 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $597.07 | 2019-2025 | Xifaxan |
| Amgen INC. | $565.96 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $401.90 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $292.97 | 2019-2025 | Veozah, Myrbetriq |
| Allergan, INC. | $289.22 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.39 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $226.22 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $190.81 | 2024-2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $161.90 | 2020-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $157.79 | 2019-2021 | |
| Axsome Therapeutics, INC. | $145.36 | 2024-2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $137.17 | 2019-2024 | |
| Exact Sciences Corporation | $125.65 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $118.84 | 2020-2025 | Injectafer |
| Amarin Pharma, INC. | $103.38 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $94.10 | 2022 | |
| Esperion Therapeutics, INC. | $92.10 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $87.74 | 2019-2021 | |
| Lundbeck LLC | $84.65 | 2024-2025 | Rexulti |
| Xeris Pharmaceuticals, INC. | $82.46 | 2020-2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $80.64 | 2023-2025 | General - Female Sui, Watchman Access System |
| Radius Health, INC. | $70.85 | 2023-2024 | Tymlos |
| Dynavax Technologies Corporation | $51.84 | 2023-2025 | Heplisav-B |
| Janssen Pharmaceuticals, INC | $50.33 | 2019-2021 | |
| Eisai INC. | $42.64 | 2020-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.30 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $35.70 | 2024-2025 | Voquezna |
| Corium, LLC | $34.90 | 2023 | Adlarity |
| Inspire Medical Systems, INC. | $34.80 | 2025 | Inspire |
| Corcept Therapeutics | $34.52 | 2025 | Korlym |
| Gilead Sciences, INC. | $33.79 | 2020-2022 | |
| Acella Pharmaceuticals, LLC | $32.33 | 2025 | NP Thyroid 60 |
| Merck Sharp & Dohme LLC | $31.78 | 2023 | Verquvo, Belsomra, Steglatro |
| Horizon Therapeutics Plc | $30.95 | 2022-2023 | Krystexxa |
| Genentech USA, INC. | $28.04 | 2019-2020 | |
| Nevro Corp. | $24.82 | 2021 | |
| Dexcom, INC. | $24.73 | 2024 | Dexcom G6 Transmitter |
| Shire North American Group INC | $23.46 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.37 | 2019-2020 | |
| Philips North America LLC | $19.84 | 2024 | (Ck7) Extended Holter |
| Almatica Pharma LLC | $18.40 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.90 | 2024 | Quviviq |
| Avanir Pharmaceuticals, INC. | $14.22 | 2019 | |
| Ardelyx, INC. | $13.91 | 2024 | Ibsrela |
| E.R. Squibb & Sons, L.L.C. | $11.74 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.61 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barnabas Hines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.